JYNT thejoint.com: Business Value

The Joint - graphic logo of issuer JYNT

Market fluctuations in The Joint Corp. (JYNT) shares reflect an enterprise value of 81.11. Management is effectively developing an affordable manual therapy network, focusing on profitability and expansion. Revenues are based on subscriptions, providing certain pricing power, although service costs are limited by patients' out-of-pocket funds. Business efficiency is increasing through the implementation of IT billing systems that minimize routine and administrative costs.

JYNT thejoint.com Real Price to Acquire Entire Company (11/23/2025 - 10/28/2026)
Original product of The Joint Corporation

Effective scaling of manual therapy franchising by The Joint Corp. (JYNT) management requires precise control over the business's capital intensity. Analyzing enterprise value through the sum of market capitalization and debt minus cash allows for an assessment of the actual acquisition price of the asset, revealing hidden debt loads and determining the company's objective investment attractiveness.

Competitors of The Joint Corp.

HCA Inc. - Total Enterprise Value|Tenet (THC) - Total Company Value|Fresenius Medical (FMS) - Business Value|SOLV - Real Price to Acquire Entire Company|Aggregate Business Value encompasshealth.com|Universal Health Services Inc (UHS) - Real Price to Acquire Entire Company|Aggregate Business Value DVA|RadNet Corp (RDNT) - Total Company Value|Value Adjusted for Debt and Cash Option Care Corp (OPCH)|SGRY: Enterprise Value|Total Enterprise Value premierinc.com PINC|National Vision - Enterprise Value|Progyny Inc (PGNY) - Enterprise Value|ARDT - Real Price to Acquire Entire Company|SEM (Select Medical Inc.) - Aggregate Business Value|Total Company Value ASTH|Real Price to Acquire Entire Company MEDNAX|U.S. Physical Therapy - Enterprise Value|Total Enterprise Value PNTG (Pennant Group)|ORGO - Total Company Value|NUTX - Business Value|Real Price to Acquire Entire Company Auna SA AUNA|SBC Medical Group Holdings (SBC) - Aggregate Business Value|EOLS - Real Price to Acquire Entire Company|CHS (CYH) - Aggregate Business Value|SKIN - Enterprise Value|Value Adjusted for Debt and Cash MediWound, Ltd.|biote Corp. - Enterprise Value|Total Enterprise Value docgo.com DCGO|Real Price to Acquire Entire Company P3 Health Partners|gaintherapeutics.com - Value Adjusted for Debt and Cash|Total Company Value EUDA Health Holdings Limited EUDA|BMGL: Aggregate Business Value|Total Company Value CLGN|cuprina.com.sg (CUPR) - Total Enterprise Value|CCM: Enterprise Value|Company Buyout Price AMS|Total Company Value MEDIROM Healthcare Group Inc MRM|Business Value avalon-globocare.com ALBT|Real Price to Acquire Entire Company DIH Holding US, Inc. (DHAI)|XAGE - Aggregate Business Value|Real Price to Acquire Entire Company NewGenIvf (NIVF)|ATIP - Value Adjusted for Debt and Cash|CMAX (CareMax Medical Group) - Enterprise Value|KDLY (Kindly Health) - Real Price to Acquire Entire Company|Total Company Value MODV (ModivCare Inc.)|Total Enterprise Value NVOS|SunLink Health Systems (SSY) - Total Company Value|Value Adjusted for Debt and Cash BACK (IMAC Holdings Inc)